Nomogram for survival of untreated patients with chronic lymphocytic leukemia. Ln, natural log; b2M, β2-microglobulin; F, fludarabine; FC, fludarabine and cyclophosphamide; FM, fludarabine and mitoxantrone; FCR, fludarabine, cyclophosphamide, and rituximab.